Andrew Emerson - 07 Aug 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
EVP, CFO and Treasurer
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Andrew Emerson
Issuer symbol
IDXX
Transactions as of
07 Aug 2025
Net transactions value
+$494
Form type
4
Filing time
11 Aug 2025, 18:00:21 UTC
Previous filing
10 Mar 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Emerson Andrew EVP, CFO and Treasurer ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Andrew Emerson 11 Aug 2025 0002058587

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $261,818 +1,849 +76% $141.60 4,273 07 Aug 2025 Direct F1
transaction IDXX Common Stock Tax liability $261,324 -402 -9.4% $650.06 3,871 07 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -1,849 -100% 0 07 Aug 2025 Common Stock 1,849 $141.60 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 27.3420 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
F2 Grant of option to buy 1,849 shares of Issuer common stock that vested on February 14, 2022.
F3 Not applicable.